Promising Therapeutic Strategies for Hematologic Malignancies: Innovations and Potential
Molecules · 2024
DOI: 10.3390/molecules29174280 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecules, 2024. Verfasst von Jan Jakub Lica und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Health Science, Powiśle University, 80-214 Gdańsk, Poland. Hauptthemen laut MEDLINE: Hematologic Neoplasms. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 153 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Molecules (MDPI, Basel).
Abstract (Originalsprache)
In this review we explore innovative approaches in the treatment of hematologic cancers by combining various therapeutic modalities. We discuss the synergistic potential of combining inhibitors targeting different cellular pathways with immunotherapies, molecular therapies, and hormonal therapies. Examples include combining PI3K inhibitors with proteasome inhibitors, NF-κB inhibitors with immunotherapy checkpoint inhibitors, and neddylation inhibitors with therapies targeting the tumor microenvironment. Additionally, we discuss the potential use of small molecules and peptide inhibitors in hematologic cancer treatment. These multidimensional therapeutic combinations present promising strategies for enhancing treatment efficacy and overcoming resistance mechanisms. However, further clinical research is required to validate their effectiveness and safety profiles in hematologic cancer patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Health Science, Powiśle University, 80-214 Gdańsk, Poland.
- Department of Biochemistry, Faculty of Pharmacy, Medical University of Warsaw, 02-097 Warsaw, Poland.
- Department of Biochemistry and Clinical Chemistry, Faculty of Biology, Medical University of Warsaw, 02-097 Warsaw, Poland.
- Department Medical Biology and Genetics, Faculty of Biology, University of Gdańsk, 80-308 Gdańsk, Poland.
- Department of Hematology and Transplantology, Faculty of Medicine, Medical University of Gdańsk, 80-214 Gdańsk, Poland.
ORCID-Profile: Jan Jakub Lica, Bhaskar Pradhan, Kawthar Safi, Joanna Jakóbkiewicz-Banecka
Förderung
- Molecules (MDPI, Basel)
Zitieren
APA
Lica, J. J., Pradhan, B., Safi, K., Jakóbkiewicz-Banecka, J., & Hellmann, A. (2024). Promising Therapeutic Strategies for Hematologic Malignancies: Innovations and Potential. Molecules. https://doi.org/10.3390/molecules29174280
Vancouver
Lica JJ, Pradhan B, Safi K, Jakóbkiewicz-Banecka J, Hellmann A. Promising Therapeutic Strategies for Hematologic Malignancies: Innovations and Potential. Molecules. 2024. doi:10.3390/molecules29174280
BibTeX
@article{Lica2024,
author = {Lica, Jan Jakub and Pradhan, Bhaskar and Safi, Kawthar and Jakóbkiewicz-Banecka, Joanna and Hellmann, Andrzej},
title = {Promising Therapeutic Strategies for Hematologic Malignancies: Innovations and Potential},
journal = {Molecules},
year = {2024},
doi = {10.3390/molecules29174280}
}
EUVIMED